[1] RUSSOW G, JAHN D, APPELT J, et al. Anabolic Therapies in Osteoporosis and Bone Regeneration. International Int J Mol Sci. 2018;20(1). pii: E83.
[2] COSMAN F, DE BEUR SJ, LEBOFF MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis.Osteoporos Int. 2014; 25(10):2359-2381.
[3] TATANGELO G, WATTS J, LIM K, et al. The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017.J Bone Miner Res. 2019;34(4):616-625.
[4] BURGE R, DAWSON-HUGHES B, SOLOMON DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.J Bone Miner Res. 2007;22(3):465-475.
[5] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国全科医学,2017,20(32):3963-3982.
[6] TARANTINO U, IOLASCON G, CIANFEROTTI L, et al. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology.J Orthop Traumatol. 2017;18(Suppl 1):3-36.
[7] ABDELGAWAD ME, DELAISSE JM, HINGE M, et al. Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.Histochem Cell Biol. 2016; 145(6):603-615.
[8] MARIE PJ. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.Eur J Endocrinol. 2011;165(1):1-10.
[9] HUNG T, CHANG HY. Long noncoding RNA in genome regulation. RNA Biol. 2010;7(5):582-585
[10] RICHARD BOLAND C. Non-coding RNA: It's Not Junk.Dig Dis Sci. 2017;62(5):1107-1109.
[11] TAKASAKI M, KONOSHIMA T, MURATA Y, et al. Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori. Cancer Lett. 2003;198(1):37-42.
[12] CHEN WJ, WANG J, QI XY, et al. The antioxidant activities of natural sweeteners, mogrosides, from fruits of Siraitia grosvenori. Int J Food Sci Nutr. 2007;58(7):548-556.
[13] LIU H, QI X, YU K, et al. AMPK activation is involved in hypoglycemic and hypolipidemic activities of mogroside-rich extract from Siraitia grosvenorii (Swingle) fruits on high-fat diet/streptozotocin-induced diabetic mice. Food Funct.2019;10(1):151-162.
[14] 姚顺晗,廖亮,覃家港,韦华成.罗汉果皂苷V刺激成骨细胞增殖与分化[J].中国组织工程研究,2019,23(29):4701-4706.
[15] REFAI NS, LOUKA ML, HALIM HY, et al. Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance. J Gene Med. 2019;21(9):e3112.
[16] SUN Z, HUANG G, CHENG H. Transcription factor induces the up-regulation of lncRNA to promote progression and adriamycin resistance in urothelial carcinoma of the bladder.Cancer Manag Res. 2019;11:6079-6090.
[17] ZHANG Z, XIONG R, LI C, et al. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.Acta Biochim Biophys Sin (Shanghai). 2019;51(8):826-833.
[18] CHEN J, YU W, RUAN Z. TUG1/miR-421/PINK1: A potential mechanism for treating myocardial ischemia-reperfusion injury.Int J Cardiol. 2019;292:197.
[19] ZHOU H, WANG B, YANG YX, et al. Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature. Biomed Res Int. 2019;2019:7159592.
[20] LIU J, LIN J, LI Y, et al. Prognostic role of LncRNA TUG1 for cancer outcome: Evidence from 840 cancer patients.Oncotarget.2017; 8(30): 50051-50060.
[21] YANG L, YANG J, PAN T, et al. Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis.J Endocrinol Invest. 2019;42(9):1125-1131.
[22] CHEN X, WANG Z, DUAN N, et al. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99-107.
[23] YANG G, LU X, YUAN L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097-1109.
[24] HUANG Y, ZHENG Y, JIA L, et al. Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-β1/Smad3/HDAC Signaling Pathway by Deriving miR-675.Stem Cells. 2015;33(12):3481-3492.
[25] CHEN L, SONG Z, HUANG S, et al. lncRNA DANCR suppresses odontoblast-like differentiation of human dental pulp cells by inhibiting wnt/β-catenin pathway.Cell Tissue Res. 2016;364(2):309-318.
[26] KOROMILA T, BANIWAL SK, SONG YS, et al. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells. J Cell Biochem. 2014;115(1):27-33.
[27] FLORES MV, LAM EY, CROSIER P, et al. A hierarchy of Runx transcription factors modulate the onset of chondrogenesis in craniofacial endochondral bones in zebrafish.Dev Dyn. 2006;235(11): 3166-3176.
[28] 张弘,姚宇,孙佳栋,等.NELL-1调控RUNX2的P1启动子诱导成骨分化[J].中华口腔医学研究杂志(电子版),2017,11(4):197-203.
[29] QIN X, JIANG Q, MATSUO Y, et al. Cbfb regulates bone development by stabilizing Runx family proteins.J Bone Miner Res. 2015;30(4): 706-714.
[30] FOSTER BL, AO M, SALMON CR, et al. Osteopontin regulates dentin and alveolar bone development and mineralization. Bone. 2018;107: 196-207.
[31] HOSSEINI S, NADERI-MANESH H, VALI H, et al. Contribution of osteocalcin-mimetic peptide enhances osteogenic activity and extracellular matrix mineralization of human osteoblast-like cells. Colloids Surf B Biointerfaces. 2019;173:662-671.
[32] ZHANG W, CHEN J, TAO J, et al. The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials. 2013;34(3):713-723.
[33] YOUNG TL, MATSUDA T, CEPKO CL. The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol.2005;15(6):501-512.
[34] 熊乐,卢婍,刘安文.长链非编码RNA TUG1在恶性肿瘤中的研究进展[J].临床与实验病理学杂志,2017,33(4):425-428.
[35] KHALIL AM, GUTTMAN M, HUARTE M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.Proc Natl Acad Sci U S A. 2009;106(28):11667-11672.
[36] LIU SC, SUN QZ, QIAO XF, et al. LncRNA TUG1 influences osteoblast proliferation and differentiation through the Wnt/β-catenin signaling pathway.Eur Rev Med Pharmacol Sci.2019;23(11):4584-4590.
|